🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 249845306 (prev. 249845108 )
- Market Cap
- Micro Cap
- IPO
- 8/13/2021 · $7.00/share
Business: Dermata Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2014 focused on developing and commercializing products for the treatment of various skin disease and multiple aesthetic skin conditions.
Notes: March 13, 2023 -- Dermata Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware (the “Certificate of Amendment”), which will effect, at 12:01 a.m. Eastern Time, on March 14, 2023, a 1-for-16 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of common stock, par value $0.0001 per share (the “Common Stock”). In connection with the Reverse Stock Split, the CUSIP number for the Common Stock will change to 249845306.
Company Contact
- CEO
- Gerald Proehl
- CFO
- Kyri Van Hoose
- Headquarters
- 3525 Del Mar Heights Rd., #322, San Diego, CA 92130
- Phone
- 858-800-2543
- Investor Relations
- Sean Proehl · 858-800-2541 · sproehl@dermatarx.com